+ Follow pulmonary disease Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1957072
[Title] => Vaping-linked lung injury may be caused by toxic fumes, study says
[Summary] => Lung biopsies from 17 people affected by a US outbreak of severe pulmonary disease linked to vaping have revealed the injuries are consistent with exposure to noxious chemical fumes, scientists reported Wednesday.
[DatePublished] => 2019-10-03 13:18:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => https://media.philstar.com/photos/2019/10/03/vape_2019-10-03_13-18-42179_thumbnail.jpg
)
[1] => Array
(
[ArticleID] => 1932550
[Title] => COPD’s month of danger
[Summary] => New use of inhaled long-acting beta, agonists or long-acting antimuscarinic antagonists was associated with a 1.5-fold increased cardiovascular risk within 30 days of initiation in patients with chronic obstructive pulmonary disease, irrespective of prior cardiovascular disease status and history of exacerbations, according to a review of more than 280,000 COPD patients in Taiwan.
[DatePublished] => 2019-07-07 00:00:00
[ColumnID] => 136231
[Focus] => 1
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
pulmonary disease
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1957072
[Title] => Vaping-linked lung injury may be caused by toxic fumes, study says
[Summary] => Lung biopsies from 17 people affected by a US outbreak of severe pulmonary disease linked to vaping have revealed the injuries are consistent with exposure to noxious chemical fumes, scientists reported Wednesday.
[DatePublished] => 2019-10-03 13:18:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => https://media.philstar.com/photos/2019/10/03/vape_2019-10-03_13-18-42179_thumbnail.jpg
)
[1] => Array
(
[ArticleID] => 1932550
[Title] => COPD’s month of danger
[Summary] => New use of inhaled long-acting beta, agonists or long-acting antimuscarinic antagonists was associated with a 1.5-fold increased cardiovascular risk within 30 days of initiation in patients with chronic obstructive pulmonary disease, irrespective of prior cardiovascular disease status and history of exacerbations, according to a review of more than 280,000 COPD patients in Taiwan.
[DatePublished] => 2019-07-07 00:00:00
[ColumnID] => 136231
[Focus] => 1
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest
